510(k) Report

510(k) · Decided

Decided

Bullseye Biliary Stent System

K082093510(k) TraditionalDecided Jul 29, 2009370-day reviewClass II21 CFR 876.5010

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Squareone · FGE Stents, Drains And Dilators For The Biliary Ducts

Cleared on Jul 29, 2009 as substantially equivalent to K010411 (Cordis Corp., 2001) and 1 other predicate after a 370-day review. Its family tree reaches back 2 generations to 2002. 1 later device descends from it.

Decided
Jul 29, 2009
Review
370 days
Class
Class II
Product code
FGE
Recalls
None
Predicates
2

Its longest line of descent runs back 2 generations to K020682 (2002). 3 ancestors in all, the oldest K010411 (2001). 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2001: 1 other ancestor2012: 1 descendant clearedK020682 · Bard Luminexx 6 FR Biliary Stent and Delivery System · C.R. Bard, Inc. · 2002K033497 · Bard Luminexx 3 Biliary Stent and Delivery System · C.R. Bard, Inc. · 2004 · recalled200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor 1 generation forward: 1 descendant K033497 · Bard Luminexx 3 Biliary Stent and Delivery System · C.R. Bard, Inc. · 2004 · recalledK020682 · Bard Luminexx 6 FR Biliary Stent and Delivery System · C.R. Bard, Inc. · 20020
  1. Root · 2 generations backK020682 Bard Luminexx 6 FR Biliary Stent and Delivery SystemC.R. Bard, Inc. · 2002
  2. 1 generation backK033497 Bard Luminexx 3 Biliary Stent and Delivery SystemC.R. Bard, Inc. · 2004 · Recalled
  3. This deviceK082093 Bullseye Biliary Stent SystemSquareone · 2009
  4. Descendant · cites it directly · 0 of its ownK113582 Archstent Biliary SystemOstial Corporation · 2012

Most influential descendants

Showing 1 of 1 · See all
  • K113582Archstent Biliary SystemOstial Corporation · 2012 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K020682Bard Luminexx 6 FR Biliary Stent and Delivery SystemC.R. Bard, Inc.2002—
−1K033497Bard Luminexx 3 Biliary Stent and Delivery SystemC.R. Bard, Inc.20041
0 (this device)K082093Bullseye Biliary Stent SystemSquareone2009—
+1K113582Archstent Biliary SystemOstial Corporation2012—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200110

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201210
FIG. 1 — Lineage of K082093, 2002–2012Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FGE? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FGE device

  1. #1 K240464 WallFlex Biliary RX Stent System; Epic Biliary…score 14.5 · 13 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K010411Palmaz Genesis Transhepatic Billary Stent and Delivery System
Summary page 1
…nd comparisons demonstrate that the BullEye Biliary Stent System is substantially equivalent to the Cordis PALMAZ GENESIS Transhepatic Biliary Stent and Delivery System (K010411) and the Bard LUMINEXX 3 Biliary Stent and Delivery System (K033497) in terms of composition, design, intended use, and performan…
Cordis Corp.20011
*K033497Bard Luminexx 3 Biliary Stent and Delivery System
Summary page 1
…substantially equivalent to the Cordis PALMAZ GENESIS Transhepatic Biliary Stent and Delivery System (K010411) and the Bard LUMINEXX 3 Biliary Stent and Delivery System (K033497) in terms of composition, design, intended use, and performance attributes. /~ ~ ~~~~ ~~ ~ ~ ~~~~…
C.R. Bard, Inc.20041

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K113582Archstent Biliary SystemOstial Corporation20120

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 7 years and passes through 2 companies; a new generation was cleared every 5.5 years on median.
  • 2 of the 3 ancestors have a recall of any class.
  • Of its descendants, K113582 (Ostial Corporation, 2012) has gone furthest, with 0 descendants of its own.

How does its category compare?

All FGE devices

FGE Stents, Drains And Dilators For The Biliary Ducts: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.

FDA decisions per year · FGE

7in 2025

2007: 42008: 112009: 72010: 92011: 92012: 82013: 52014: 82015: 82016: 42017: 92018: 72019: 22020: 42021: 12022: 62023: 62024: 62025: 72026 (partial year): 8
2007high 11 (2008) · low 1 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FGE

257in 2025

2007: 316 days median2008: 214 days median2009: 160 days median2010: 81 days median2011: 114 days median2012: 96 days median2013: 161 days median2014: 156 days median2015: 79 days median2016: 49 days median2017: 59 days median2018: 215 days median2020: 121 days median2022: 101 days median2023: 199 days median2024: 188 days median2025: 257 days median2026 (partial year): 153 days median
2007high 316 (2007) · low 49 (2016)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FGE

1in 2024

2007: 542008: 932009: 182010: 322011: 22012: 42013: 32017: 12018: 432019: 132020: 12021: 272022: 212023: 192024: 12026 (partial year): 11
2007high 93 (2008) · low 0 (2014)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · FGE

1,923in 2025

2007: 1,0062008: 1,4652009: 1,6552010: 1,4342011: 1,3212012: 1,1832013: 1,0602014: 1,2702015: 1,5432016: 1,4532017: 1,5152018: 1,6812019: 1,8962020: 2,1822021: 2,2972022: 1,7492023: 1,6152024: 1,9482025: 1,923
2007high 2,297 (2021) · low 1,006 (2007)2025

MAUDE reports naming product code FGE, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20074316541,006
200811214931,465
20097160181,655
2010981321,434
2011911421,321
201289641,183
2013516131,060
2014815601,270
201587901,543
201644901,453
201795911,515
20187215431,681
20192—131,896
2020412112,182
20211—272,297
20226101211,749
20236199191,615
2024618811,948
2025725701,923
2026815311—

What is it indicated for?

BullsEye Biliary Stent System is indicated for use in the palliation of malignant neoplasms in the biliary tree.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K082093: Bullseye Biliary Stent System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K082093

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026